- Adaptive desgins in individualized therapy
- AdCo-Studie
- Aided-Trial
- AIEOP-BFM ALL 2009
- AliCLE-Studie
- AML-AZA-Studie
- APREPRU-Studie
- AXADIA
- BARGRU
- BARGRU II
- BIBF 1120 in AML
- BigpAK-2
- ClinicStartT
- ClaiMS
- CRITSCH-Register
- DIMAT-MS
- Doxo-Studie
- ELAIN-Studie
- Empirische Analyse der Darmkarzinomtherapie des in NRW existierenden Netzwerkes von Kliniken mit Zertifizierung zur Behandlung von Darmkrebs im Vergleich zu nicht zertifizierten Kliniken
- EPIS-AKI
- ES-RiP
- EURAMOS-1-Studie
- Evaluation des Pulsoxymetrie-Screenings (POS)
- EWING
- Fabry Disease
- FlowOX
- FumaCLE-Studie
- GDL-ISRT 20 Gy
- GenderVasc
- GISG-SKIN-Studie
- Glacé-Trial
- HandiCAP
- HIT 2000
- HIT-Endo/Kraniopharyngiom
- HIT-Life
- HIT-REZ
- InMediValue
- Internetbasierte Umfrage zur Hornhaut-Spendenbereitschaft
- KoKris
- Machine learning and complex data analysis of immunophenotyping data in multiple sclerosis
- MTX Withdrawal in JIA
- Multizentrische radiologische Lymphomstudie
- NB2004
- NOA11-Studie
- OptAHF
- oVID
- PARTNER-Studie
- PAZOPANIB-AML-Studie
- PrevAKI multicenter
- PREVENT-JIA
- PRIVIRON-Studie
- Prognostic performance of a genetic risk score for melanoma
- PSA-Inform
- QUARKS - LQ/RESILIENZ BEI KMT
- Real-time information extraction from data streams
- Revisiting the Stroop test a a measure of cognitive deficits in Huntington's Disease
- RICH-Trial
- Riliva
- RIPCRenal
- RISK-Studie
- RTPS 1+2
- SacBo-Studie
- SIOP-LGG 2004
- SMN after sarcomas
- SoLKID
- Statistical testing and Dose-Adaptation simultaneously
- Studienallianz Leukämie (SAL)
- Studie zur verkürzten Zahnreihe
- SunCLE-Studie
- T.I.M.E.
- tTF-NGR
- WIN-SAB
